Pierre Gosset Selected Research

Pierre Gosset Research Topics

Disease

11	Infections 01/2022 - 12/2009
10	Neoplasms (Cancer) 12/2017 - 12/2013
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 11/2015
4	Prostatic Neoplasms (Prostate Cancer) 03/2017 - 07/2011
3	Lung Neoplasms (Lung Cancer) 04/2018 - 06/2009
3	Pneumonia (Pneumonitis) 01/2017 - 06/2013
3	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 01/2015
2	Carcinogenesis 01/2018 - 01/2017
2	Virus Diseases (Viral Diseases) 01/2017 - 03/2012
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 03/2015
2	Bacterial Infections (Bacterial Infection) 11/2015 - 06/2013
2	Neoplasm Metastasis (Metastasis) 03/2015 - 12/2013
1	Inflammation (Inflammations) 01/2022
1	Metaplasia 01/2022
1	Atrophy 01/2022
1	Haemophilus Infections 01/2017
1	Airway Remodeling 01/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017
1	Pathologic Processes 01/2017
1	Aberrant Crypt Foci 01/2016
1	Pneumococcal Infections 11/2015
1	Mesothelioma 08/2015
1	Adenocarcinoma of Lung 08/2015
1	Malignant Mesothelioma 08/2015
1	Superinfection 06/2013
1	Human Influenza (Influenza) 06/2013
1	Communicable Diseases (Infectious Diseases) 06/2013
1	Stomach Diseases 09/2012
1	Adenocarcinoma 01/2012
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2012
1	Brain Neoplasms (Brain Tumor) 03/2011

Drug/Important Bio-Agent (IBA)

5	Interleukin-22 (IL-22)IBA 01/2017 - 03/2012
4	SmokeIBA 01/2021 - 11/2015
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2011
3	AntigensIBA 12/2017 - 12/2009
3	Ion Channels (Ion Channel)IBA 03/2017 - 12/2013
3	CalciumIBA 03/2017 - 12/2013
3	CytokinesIBA 01/2017 - 03/2012
3	MucinsIBA 01/2015 - 03/2011
2	LigandsIBA 01/2021 - 03/2015
2	FlagellinIBA 01/2021 - 01/2017
2	InterleukinsIBA 01/2021 - 01/2017
2	ParaffinIBA 03/2017 - 07/2011
2	TRPA1 Cation ChannelIBA 03/2017 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2017 - 01/2017
2	Formaldehyde (Formol)FDA Link 03/2017 - 07/2011
2	Gastric MucinsIBA 01/2016 - 06/2015
2	Polysaccharides (Glycans)IBA 06/2015 - 01/2015
1	AntralIBA 01/2022
1	Toll-Like Receptor 5IBA 01/2021
1	Vehicle Emissions (Emissions, Vehicle)IBA 04/2018
1	Biological ProductsIBA 12/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2017
1	Triclosan (pHisoHex)FDA Link 03/2017
1	CationsIBA 03/2017
1	5-aminolevulinic acid hexyl ester FDA Link 01/2017
1	ResveratrolIBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	AnkyrinsIBA 01/2017
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Contrast MediaIBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 11/2015
1	UreaseIBA 09/2015
1	Clarithromycin (Biaxin)FDA LinkGeneric 09/2015
1	ClaudinsIBA 08/2015
1	Claudin-3IBA 08/2015
1	Chemokine ReceptorsIBA 03/2015
1	Pharmaceutical PreparationsIBA 03/2015
1	ChemokinesIBA 03/2015
1	Calcium Channels (Calcium Channel)IBA 09/2014
1	Proteins (Proteins, Gene)FDA Link 12/2013
1	MetalsIBA 12/2013
1	bisphenol AIBA 12/2013
1	PlasticsIBA 12/2013
1	CarbohydratesIBA 09/2012
1	EpitopesIBA 09/2012
1	LipidsIBA 03/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2012
1	Glycoproteins (Glycoprotein)IBA 03/2011
1	Cysteine (L-Cysteine)FDA Link 03/2011
1	Scavenger Receptors (Scavenger Receptor)IBA 03/2011
1	CarcinogensIBA 06/2009

Therapy/Procedure

1	Lasers (Laser) 01/2017
1	Aftercare (After-Treatment) 01/2016
1	Therapeutics 08/2015
1	Neoadjuvant Therapy 03/2015
1	Drug Therapy (Chemotherapy) 03/2015
1	Adjuvant Chemotherapy 01/2015